Assessing AI transformation in pharma R&D: Current and future impact

Published on December 5, 2024

Artificial intelligence (AI) has been one of the largest disruptors in drug development over the past few years, with the promise of innovation and greater efficiencies keeping the pharma industry heavily invested. There have been major advancements in AI-discovered molecules and AI-powered platforms for decentralized treatment, in addition to many more AI applications that have […]

Continue reading on website
Other news

Harnessing lab data to speed time to treatment

December 5, 2024
In recent years, pharma companies have begun to embrace lab data as a richly rewarding dataset for a whole host of purposes, including trial enrollment and site identification, patient monitoring and disease progression, and commercial targeting and market access insights. Along with test orders, values, and results, deidentified lab data includes a wealth of information, […]

Mount Sinai and U.S. Anesthesia Partners Form Alliance to Support New Anesthesia Practice

December 5, 2024
Mount Sinai and U.S. Anesthesia Partners Form Alliance to Support New Anesthesia Practice Jodi_LewisThu, 12/05/2024 - 08:44Read more about Mount Sinai and U.S. Anesthesia Partners Form Alliance to Support New Anesthesia Practice